Tag Archives: Latrepirdine

Review of Interventions Which May Potentially Delay Functional Decline in Persons With Dementia (BMJ Open)

Posted on April 30, 2016 by Dementia and Elderly Care News

Summary The authors examined 23 systematic reviews about the benefits of non-pharmacological, pharmacological and alternative therapies on activities of daily living (ADL) in people with dementia. Interventions thought to be effective (based on evidence sometimes judged to be “low quality”) … Continue reading →

Posted in Commissioning, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged Acetylcholinesterase Inhibitors, Acetylcholinesterase Inhibitors (AChEIs), Activities of Daily Living, Activities of Daily Living (ADL), Acupuncture, Ageing Work and Health Research Unit: University of Sydney, Anti-Dementia Medication, Aromatherapy, Aromatherapy for Dementia, Australia, BMJ Open, BMJ Publishing Group Ltd, Bright Light Therapy, Carer Burden in Dementia, Case Management, Case Management for Dementia, Cognitive Stimulation, Cognitive Stimulation Therapy, Cognitive Training, Cognitive Training Exercises, Department of Rehabilitation Aged and Extended Care: Flinders University, Depression and Anxiety, Donepezil, Dyadic Interventions, Dyadic Interventions For Community-Dwelling People With Dementia and Their Family Caregivers, Enabling Activities of Daily Living, Family Caregivers, Family Carers, Flinders University, Flinders University (Adelaide), Functional Decline, Gingko Biloba, Ginkgo Biloba, Ginkgo Biloba Extract, Health and Quality of Life, Huperzine A, Improving the Quality of Life for People With Dementia, Improving the Quality of Life for People with Long Term Conditions, Interventions to Delay Functional Decline in Persons With Dementia, Latrepirdine, Latrepirdine (Dimebon), Lecithin, Light Therapy, Light Therapy for Dementia, Maintaining Independence, Maintenance Cognitive Stimulation Therapy (CST), Melatonin, Memantine, Metal Protein Attenuating Compounds (MPACs), MPACs: Metal Protein Attenuating Compounds, Music Therapy, Music Therapy for BPSD, New South Wales, Nimodipine, Nutritional Interventions, Nutritional Supplementation, Nutritional Supplements, Patient-Carer Dyads, Pharmacotherapies for Sleep Disturbances, Physical Exercise, Physical Exercise Programmes, Post Market Review Pharmaceutical Benefits Scheme: Anti-Dementia Medicines, Psychological Treatments for Depression and Anxiety, Quality of Life, Quality of Life for People With Dementia, Quality of Life Promotion, Selegiline, Services Maximising Independence, South Australia, Statins, Supporting Health Wellbeing and Independence, Systematic Reviews and Meta-Analyses, University of Sydney, Validation Therapy, Vitamin B12, Vitamin B6, Vitamins B Supplementation | Leave a comment

Latrepirdine for Alzheimer’s Disease: Systematic Review (Cochrane Database of Systematic Reviews)

Posted on May 15, 2015 by Dementia and Elderly Care News

Summary This systematic review investigated the potential of Latrepirdine as a disease-modifying intervention for Alzheimer’s Disease. The evidence suggests, so far, that Latrepirdine has no beneficial effect on cognition and / or function in patients. The authors of this review … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Pharmacological Treatments, Quick Insights, Systematic Reviews | Tagged 2 3 4 5-Tetrahydro-2, 8-Dimethyl-5- (2-(6-Methyl-3-Pyridyl)Ethyl)-1H-Pyrido(4 3-b)Indole, Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Alzheimer's Disease Co-operative Study - Activities of Daily Living Scale (ADCS-ADL), Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)), Alzheimer’s Disease Cooperative Study / Activities of Daily Living (ADCS-ADL) Inventory, Canada, Clinician’s Interview-Based Impression of Change Plus Caregiver Input (CIBIC-Plus), Cochrane Database of Systematic Reviews, CONCERT, CONNECTION, Dimebolin, Dimebon, Disease-Modifying Therapies for Dementia, Latrepirdine, Latrepirdine (Dimebon), Latrepirdine for Alzheimer’s Disease, Lipid Peroxidation, Mini Mental State Examination (MMSE), Mitochondrial Permeability, Neuropsychiatric Inventory (NPI), Neurotransmitter Receptor Activity, Severe Impairment Battery (SIB), Sunnybrook Health Sciences Centre (Toronto), Sunnybrook Research Institute: Brain Sciences Research Program, Systematic Reviews and Meta-Analyses, University of Toronto, Voltage-Gated Calcium Ion Channels | Leave a comment

Tag Archives: Latrepirdine

Review of Interventions Which May Potentially Delay Functional Decline in Persons With Dementia (BMJ Open)

Latrepirdine for Alzheimer’s Disease: Systematic Review (Cochrane Database of Systematic Reviews)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites